Results 231 to 240 of about 9,754 (250)

Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial

Nature Medicine, 2021
Tien Dam, Adam L Boxer, Günter U Höglinger   +2 more
exaly  

Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies

Nature Reviews Neurology, 2021
Maria Stamelou, Gesine Respondek, Jennifer L Whitwell   +2 more
exaly  

Mutations disrupting neuritogenesis genes confer risk for cerebral palsy

Nature Genetics, 2020
Sheng Chih Jin, Sara A Lewis, Xue Zeng
exaly  

State of the Evidence Traffic Lights 2019: Systematic Review of Interventions for Preventing and Treating Children with Cerebral Palsy

Current Neurology and Neuroscience Reports, 2020
Iona Novak, Catherine Morgan, Michael Fahey   +2 more
exaly  

Cerebral palsy

Nature Reviews Disease Primers, 2016
Kerr Graham, Peter L Rosenbaum, Nigel Paneth   +2 more
exaly  

The complex aetiology of cerebral palsy

Nature Reviews Neurology, 2018
Steven James Korzeniewski, Nigel Paneth
exaly  

Distribution patterns of tau pathology in progressive supranuclear palsy

Acta Neuropathologica, 2020
Gabor G Kovacs, Edward B Lee, David Coughlin   +2 more
exaly  

Rehabilitation and neuroplasticity in children with unilateral cerebral palsy

Nature Reviews Neurology, 2015
Lee B Reid, Stephen E Rose, Roslyn Boyd
exaly  

Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches

Lancet Neurology, The, 2017
Adam L Boxer, , Anthony E Lang
exaly  

An update on the prevalence of cerebral palsy: a systematic review and meta‐analysis

Developmental Medicine and Child Neurology, 2013
Maryam Oskoui, Tamara Pringsheim
exaly